Patent Open Access

An Antiviral Formulation with RNA Dependent RNA Polymerase & DNA Gyrase Suppressive Properties for the Treatment of Emerging Covid-19 Subvariants

Alkoclar, Erdal Can; Yesil, Metehan

A bioceutical formulation consisting of RNA Polymerase inhibiting and immunomodulatory features- exhibiting Glucopyranoside Analouges for the Adjunctive Treatment of Emerging Covid-19 Subvariants.

 

Inventors: Erdal Can Alkoclar & Metehan Yesil

Files (77.3 kB)
Name Size
edd4184f-a69b-4f51-ba23-5b6a2a63b260 4.pdf
md5:c1ba22cf6e020b70236675a153c65af2 		77.3 kB Download
0
0
views
downloads
All versions This version
Views 00
Downloads 00
Data volume 0 Bytes0 Bytes
Unique views 00
Unique downloads 00
More info on how stats are collected.
Indexed in
Publication date:
July 8, 2022
DOI:
10.82163/sciencerepository.24

Zenodo DOI Badge

DOI 

10.82163/sciencerepository.24

Markdown 

[![DOI](https://sciencerepository.dk/badge/DOI/10.82163/sciencerepository.24.svg)](https://doi.org/10.82163/sciencerepository.24)

reStructedText 

.. image:: https://sciencerepository.dk/badge/DOI/10.82163/sciencerepository.24.svg
   :target: https://doi.org/10.82163/sciencerepository.24

HTML 

<a href="https://doi.org/10.82163/sciencerepository.24"><img src="https://sciencerepository.dk/badge/DOI/10.82163/sciencerepository.24.svg" alt="DOI"></a>

Image URL 

https://sciencerepository.dk/badge/DOI/10.82163/sciencerepository.24.svg

Target URL 

https://doi.org/10.82163/sciencerepository.24

Keyword(s):
Omicron covid-19
Communities:
License (for files):
Creative Commons Attribution 4.0 International

Versions

Version 1.0 10.82163/sciencerepository.24 Jul 8, 2022
Cite all versions? You can cite all versions by using the DOI 10.5281/zenodo.23. This DOI represents all versions, and will always resolve to the latest one. Read more.

Share

Cite as

Export